Olaris Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $15M

  • Investors
  • 10

Olaris General Information

Description

Developer of a precision diagnostics platform designed to identify biomarkers of treatment response. The company uses metabolite profiling and customized machine learning algorithms to determine therapy response and associated outcomes, enabling biopharmaceutical companies to improve treatment efficacy and reduce adverse events.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 175 Crossing Boulevard
  • Suite 410
  • Framingham, MA 01702
  • United States
+1 (617)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 175 Crossing Boulevard
  • Suite 410
  • Framingham, MA 01702
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Olaris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B1) 11-Apr-2025 $15M Completed Generating Revenue
6. Later Stage VC (Series B) 21-Sep-2021 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Sep-2019 Completed Generating Revenue
4. Seed Round 01-Jan-2019 Completed Generating Revenue
3. Grant 23-Jul-2018 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Olaris’s complete valuation and funding history, request access »

Olaris Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B
Series A-3
Series A-2 1,246,622 $0.000100 $0.09 $1.54 $1.54 1x $1.54 6.61%
Series A-1 2,175,146 $0.000100 $0.12 $1.93 $1.93 1x $1.93 11.53%
To view Olaris’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Olaris Patents

Olaris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4695602-A1 Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients Pending 20-Oct-2023
WO-2025085668-A1 Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients Inactive 20-Oct-2023
WO-2025085668-A9 Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients Inactive 20-Oct-2023
EP-4288774-A1 Device, method and system for monitoring immune system response Pending 01-Mar-2021
EP-4288774-A4 Device, method and system for monitoring immune system response Pending 01-Mar-2021 G01N33/5008
To view Olaris’s complete patent history, request access »

Olaris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Olaris Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Labcorp Venture Fund Corporate Venture Capital Minority
Northpoint Capital Group PE/Buyout Minority
Angel (individual) Minority
U.S. Boston Growth Capital Growth/Expansion Minority
Next Act Fund Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Olaris FAQs

  • When was Olaris founded?

    Olaris was founded in 2014.

  • Where is Olaris headquartered?

    Olaris is headquartered in Framingham, MA.

  • What is the size of Olaris?

    Olaris has 17 total employees.

  • What industry is Olaris in?

    Olaris’s primary industry is Discovery Tools (Healthcare).

  • Is Olaris a private or public company?

    Olaris is a Private company.

  • What is the current valuation of Olaris?

    The current valuation of Olaris is .

  • What is Olaris’s current revenue?

    The current revenue for Olaris is .

  • How much funding has Olaris raised over time?

    Olaris has raised $29M.

  • Who are Olaris’s investors?

    Labcorp Venture Fund, Northpoint Capital Group, , U.S. Boston Growth Capital, and Next Act Fund are 5 of 10 investors who have invested in Olaris.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process